Preliminary study of mucosal IgA in the equine small intestine: specific IgA in cases of acute grass sickness and controls.
Authors: Nunn F G, Pirie R S, McGorum B, Wernery U, Poxton I R
Journal: Equine veterinary journal
Summary
# Editorial Summary Equine grass sickness (EGS) is a devastating condition with strong epidemiological links to Clostridium botulinum toxin exposure, yet the protective mechanisms that prevent disease in exposed horses remain poorly understood. Nunn and colleagues examined whether specific immunoglobulin A (IgA) antibodies in the small intestinal mucosa—the first line of immune defence at the mucosal surface—could be detected in affected and unaffected horses, hypothesising that mucosal immunity might explain why some horses resist EGS despite potential toxin exposure. Using intestinal biopsy samples, they measured mucosal IgA levels against C. botulinum in horses with acute EGS, clinically normal control horses, and horses with other GI diseases. The preliminary findings demonstrated detectable specific IgA responses in control horses, suggesting that local intestinal immunity develops following exposure; critically, horses with acute EGS showed altered mucosal antibody patterns, implying that breakdown or insufficiency of this mucosal defence mechanism may contribute to disease pathogenesis. For equine practitioners, these results indicate that mucosal immunity warrants further investigation as a potential protective factor and therapeutic target, with implications for understanding why vaccination or management strategies might fail in some at-risk populations and opening avenues for novel preventative approaches based on mucosal immunocompetence rather than systemic antibody titres alone.
Read the full abstract on PubMed
Practical Takeaways
- •Mucosal immunity in the GI tract may be a key protective mechanism against grass sickness; understanding this could inform prevention strategies
- •Testing for specific mucosal IgA rather than relying solely on blood antibodies may provide better assessment of protection status in at-risk horses
- •Horses with adequate mucosal IgA responses may have improved resistance to grass sickness, suggesting potential for targeted management or vaccination approaches
Key Findings
- •Specific mucosal IgA antibodies against Clostridium botulinum can be detected in the equine small intestine
- •IgA levels in the gastrointestinal tract appear to correlate with disease state and resistance to equine grass sickness
- •High serum antibody levels previously associated with disease resistance may be complemented by mucosal immune responses